Chronic beryllium disease is an occupational lung disease that begins as a cell-mediated
immune response to beryllium. Although respiratory and engineering controls have …

Beryllium exposure can cause a granulomatous lung disease in workers who develop a
lymphocyte-mediated sensitization to the metal. Workers in diverse industries are at risk …

The blood beryllium lymphocyte proliferation test is used in medical surveillance to identify
both beryllium sensitization and chronic beryllium disease. Approximately 50% of …

With the advent of in vitro immunologic testing, we can now detect exposed individuals who
are sensitized to beryllium and those who have chronic beryllium disease (CBD) with lung …

Objective: Workers at a beryllium ceramics plant were tested for beryllium sensitization and
disease in 1998 to determine whether the plant-wide prevalence of sensitization and …

We examined the relationship between exposure to beryllium and the presence of beryllium
sensitization (BeS) and chronic beryllium disease (CBD) in a cohort of workers in a beryllium …

Chronic granulomatous lung disease caused by industrial exposure to beryllium continues
to occur, but no community cases have been reported in more than 30 yr. With the advent of …

Background Chronic beryllium disease (CBD), which primarily affects the lungs, occurs in
sensitized beryllium‐exposed individuals. At a copper–beryllium alloy strip and wire …

Rationale: Beryllium continues to have a wide range of industrial applications. Exposure to
beryllium can lead to sensitization (BeS) and chronic beryllium disease (CBD). Objectives …

We evaluated the beryllium-specific lymphocyte transformation test as a workplace
screening tool for early beryllium disease. Fifty-one of 58 workers with current beryllium …